Cetuximab and haemoglobin decreased Patient Reports February 11, 2012

Cetuximab Side Effects Report #5311714-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2007. Male patient, weighting 157.3 lb, was diagnosed with tonsil cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dry mouth, haemoglobin decreased, mucosal inflammation, neutrophil count decreased, platelet count decreased, post procedural haemorrhage, procedural hypotension, white blood cell count increased. Cetuximab dosage: 250 MG/M2 IV WEEKLY. During the same period patient was treated with CISPLATIN, DURAGESIC, SALAGEN, ALPRAZOLAM, MAGNESIUM OXIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, CENTRUM. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5328769-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 16, 2007. Male patient, weighting 157.3 lb, was diagnosed with tonsil cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dry mouth, haematocrit decreased, haemoglobin decreased, hypotension, mucosal inflammation, platelet count decreased, post procedural haemorrhage, procedural hypotension. Cetuximab dosage: 250MG/M2 IV WEEKLY. During the same period patient was treated with CISPLATIN, DURAGESIC, SALAGEN, ALPRAZOLAM, MAGNESIUM OXIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, CENTRUM. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4747509-9
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2005. Female patient, 80 years of age, weighting 116.8 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, febrile neutropenia, haemoglobin decreased, nausea

, neutrophil count decreased, platelet count decreased, stomatitis, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4835710-5
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2005. Female patient, 80 years of age, weighting 116.8 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, febrile neutropenia, haemoglobin decreased, nausea

, neutrophil count decreased, platelet count decreased, stomatitis, white blood cell count decreased. Cetuximab dosage: INITIAL TX DATE:20-MAY-05/TOTAL DOSE ADM THIS COURSE: 360 MG/TX SUSPENDED AT THE TIME OF THE REPORT.. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5620166-5
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2008. Male patient, 68 years of age, weighting 196.2 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5698099-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Apr 02, 2008. Male patient, 62 years of age, weighting 136.7 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: bacteraemia, blood potassium decreased, dehydration, dermatitis, dysphagia, haemoglobin decreased, hypocalcaemia, lymphopenia, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5132781-6
Cetuximab side effect was reported by a Physician from UNITED STATES on May 26, 2006. Male patient, 56 years of age, weighting 112.4 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dyspnoea, haemoglobin decreased, hypocalcaemia, hypotension, hypoxia, infection

, neutropenia, neutrophil count decreased. Cetuximab dosage: INITIATED ON 04-APR-2006 AT 400 MG/M2 F/B 250 MG/M2 WEEKLY X 9 WEEKS/TOTL DOSE THIS COURSE = 400 MG.. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 06/15/2006.

Cetuximab Side Effects Report #5500423-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2007. Male patient, 53 years of age, weighting 189.6 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dysphagia, haemoglobin decreased, hyperglycaemia, hypoalbuminaemia, hypocalcaemia, hypokalaemia, hypomagnesaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5509017-7
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient, 52 years of age, weighting 125.7 lb, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, granulocyte count decreased, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypokalaemia, hypomagnesaemia, hyponatraemia, oral pain. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #6081413-1
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Feb 05, 2009. Male patient, 78 years of age, weighting 194.0 lb, was diagnosed with prostate cancer

, vitamin supplementation, pain

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypotension, intestinal mass, myocardial infarction, neutropenia, phlebitis, tracheobronchitis. Cetuximab dosage: unknown. During the same period patient was treated with NOVANTRONE, PREDNISONE, DARVOCET, CHLORELLA. Patient was hospitalized and became disabled. Patient recovered.

Cetuximab Side Effects Report #4679314-6
Cetuximab side effect was reported by a Consumer or non-health professional from on May 26, 2005. Female patient, 75 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood creatinine increased, fatigue, haemoglobin decreased, hyperkalaemia, renal failure, sinus bradycardia, troponin t increased. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4682788-8
Cetuximab side effect was reported by a Consumer or non-health professional from on May 26, 2005. Female patient, 75 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood creatinine increased, fatigue, haemoglobin decreased, hyperkalaemia, myocardial infarction, renal failure, sinus bradycardia, troponin t increased. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 05/27/2005.

Cetuximab Side Effects Report #4668687-6
Cetuximab side effect was reported by a Consumer or non-health professional from on Apr 28, 2005. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, haemoglobin decreased, hypotension, oedema peripheral, renal failure, syncope. Cetuximab dosage: TOTAL DOSE ADMINISTERED THIS COURSE = 1508 MG.. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4679312-2
Cetuximab side effect was reported by a Consumer or non-health professional from on Apr 28, 2005. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, haemoglobin decreased, hypotension, multi-organ failure, oedema peripheral, renal failure, syncope. Cetuximab dosage: TOTAL DOSE ADMINISTERED THIS COURSE = 1508 MG.. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 05/14/2005.

Cetuximab Side Effects Report #5943510-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Male patient, 59 years of age, weighting 189.6 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood glucose increased, dehydration, extravasation, haematocrit decreased, haemoglobin decreased, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with OXALIPLATIN, GEMZAR, NEXIUM, MORPHINE SULPHATE, DILAUDID, LISINOPRIL, POLYETHYLENE GLYCOL, NOVOLOG. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4912007-6
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2006. Male patient, 58 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, diarrhoea, fatigue, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, hyponatraemia, neutrophil count decreased, thrombosis. Cetuximab dosage: 400MG/M2(DAY 1 CYCLE 1 ONLY-18-JAN)-TOTAL DOSE 740 MG,PER PROTOCOL THEN 250 MG/M2 DAY 8,15,22,29,36.. During the same period patient was treated with DOCETAXEL, IRINOTECAN, ARGATROBAN. Patient was hospitalized. Patient died on 01/31/2006.

Cetuximab Side Effects Report #4927943-4
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 58 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, cardiopulmonary failure, diarrhoea, fatigue, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, hyponatraemia, neutrophil count decreased. Cetuximab dosage: 400MG/M2(DAY 1 CYCLE 1 ONLY-18-JAN)-TOTAL DOSE 740 MG,PER PROTOCOL THEN 250 MG/M2 DAY 8,15,22,29,36.. During the same period patient was treated with DOCETAXEL, IRINOTECAN, ARGATROBAN, SYNTHROID, PROTONIX, ATACAND, COUMADIN. Patient was hospitalized. Patient died on 01/31/2006.

Cetuximab Side Effects Report #4948298-5
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 58 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, cardiopulmonary failure, diarrhoea, fatigue, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, hyponatraemia, neutrophil count decreased. Cetuximab dosage: 400MG/M2(DAY 1 CYCLE 1 ONLY-18-JAN)-TOTAL DOSE 740 MG,PER PROTOCOL THEN 250 MG/M2 DAY 8,15,22,29,36.. During the same period patient was treated with DOCETAXEL, IRINOTECAN, ARGATROBAN, SYNTHROID, PROTONIX, ATACAND, COUMADIN. Patient was hospitalized. Patient died on 01/31/2006.

Cetuximab Side Effects Report #4635974-7
Cetuximab side effect was reported by a Consumer or non-health professional from on Apr 06, 2005. Male patient, 54 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, muscular weakness, myocardial infarction, ventricular dysfunction. Cetuximab dosage: 437.5 MG TOTAL THIS COURSE.. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 04/08/2005.

Cetuximab Side Effects Report #4650149-3
Cetuximab side effect was reported by a Consumer or non-health professional from on Apr 06, 2005. Male patient, 54 years of age, weighting 141.1 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, muscular weakness, myocardial infarction, ventricular dysfunction. Cetuximab dosage: 437.5 MG TOTAL THIS COURSE.. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 04/08/2005.

Cetuximab Side Effects Report #4593800-9
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Male patient, 31 years of age, weighting 174.2 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dyspnoea, haemoglobin decreased, haemolysis, hyperbilirubinaemia, hypertension, platelet count decreased, renal failure, thrombotic microangiopathy. Cetuximab dosage: INITIATED ON 22-JUN-04. (TD ADMIN THIS COURSE=510 MG). 6 COURSES TO DATE.. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5427041-X
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, myocardial infarction. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, QUESTRAN, DARVOCET, VICODIN, REGLAN, TOPROL, NORVASC. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4608875-8
Cetuximab side effect was reported by a Health Professional from on Mar 08, 2005. Female patient, 71 years of age, weighting 158.7 lb, was diagnosed with ovarian cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: back pain

, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, bronchospasm, granulocyte count increased, haematocrit decreased, haemoglobin decreased, hypersensitivity, infusion related reaction. Cetuximab dosage: LD: 400MG/M2 ON 31-JAN-05. 250 MG/M2 STARTED ON 07-FEB-05. CUMULATIVE TOTAL DOSE TO DATE: 1202 MG.. During the same period patient was treated with CARBOPLATIN, BENADRYL, REGLAN, HYDROCHLOROTHIAZIDE, NORVASC, SEREVENT, ALBUTEROL, VITAMIN CAP. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #6035388-1
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2009. Male patient was diagnosed with oral cavity cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, syncope. Cetuximab dosage: 400 MG/M2, LOADING, IV. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4915118-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Feb 10, 2006. Female patient, 30 years of age, weighting 116.8 lb, was diagnosed with oesophageal squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: aspiration, atelectasis, culture urine positive, haemoglobin decreased, infection

, mucosal inflammation, pneumonia

, pyrexia. Cetuximab dosage: 400 MG/M2 X 1 DOSE, THEN 250 MG/M2 DAYS 1,8,22,29,36 (TOTAL 2116 MG). HELD.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5173434-8
Cetuximab side effect was reported by a Physician from UNITED STATES on Dec 08, 2006. Male patient, 45 years of age, weighting 111.3 lb, was diagnosed with oesophageal carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: condition aggravated, failure to thrive, gastrointestinal necrosis, haemoglobin decreased, hyperkalaemia, hypokalaemia, intestinal obstruction, large intestine perforation, malnutrition. Cetuximab dosage: 361 MG/M2 I.V.. During the same period patient was treated with CISPLATIN, IRINOTECAN, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 10/29/2006.

Cetuximab Side Effects Report #4781689-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 20, 2005. Male patient, 44 years of age, weighting 253.5 lb, was diagnosed with oesophageal carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: arthritis

, blood pressure decreased, colitis, dehydration, diarrhoea, gastritis erosive, haematocrit decreased, haemoglobin decreased, haemorrhoidal haemorrhage. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN, ADDERALL, ALPRAZOLAM, CARAFATE, COGENTIN, DIOVAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5872527-7
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2008. Male patient, 77 years of age, weighting 213.8 lb, was diagnosed with non-small cell lung cancer metastatic, hypertension, type 2 diabetes mellitus, constipation prophylaxis and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, epistaxis, haemoglobin decreased, platelet count decreased. Cetuximab dosage: unknown. During the same period patient was treated with PEMETREXED DI, LOPRESSOR, DIABETA, CATAPRES, ACYCLOVIR, SENOKOT, PRILOSEC, LISINOPRIL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5173809-7
Cetuximab side effect was reported by a Physician from UNITED STATES on Dec 08, 2006. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood glucose increased, blood lactate dehydrogenase increased, blood pressure diastolic increased, blood urea increased, body temperature decreased, haematocrit decreased, haemoglobin decreased, heart rate increased, hypoglycaemia. Cetuximab dosage: 380 MG IV. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, KEFLEX, HYDROCHLOROTHIAZIDE, DIOVAN, ACTOS, METFORMIN, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4611708-7
Cetuximab side effect was reported by a Consumer or non-health professional from on Mar 10, 2005. Female patient, 84 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: arrhythmia

, blood magnesium decreased, confusional state, dyspnoea, fatigue, febrile neutropenia, haemoglobin decreased, neutrophil count decreased. Cetuximab dosage: 4316MG TOTAL THIS COURSE. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4625303-7
Cetuximab side effect was reported by a Consumer or non-health professional from on Mar 10, 2005. Female patient, 84 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: arrhythmia

, blood magnesium decreased, confusional state, dyspnoea, fatigue, febrile neutropenia, haemoglobin decreased, hypoxia, hypoxic encephalopathy. Cetuximab dosage: 4316MG TOTAL THIS COURSE. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LORTAB, PROTONIX, OYSTER SHELL CALCIUM, AMBIEN. Patient was hospitalized. Patient died on 03/19/2005.

Cetuximab Side Effects Report #4783625-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2005. Male patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, dysarthria, facial palsy, fatigue, haemoglobin decreased, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4807699-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2005. Male patient, 77 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer, sleep disorder

, pain

, nausea

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood potassium decreased, blood sodium decreased, dehydration, haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased, white blood cell analysis decreased. Cetuximab dosage: INITIATED ON 09-AUG-2005. 249.7 MG/M2. ADMINISTERED IV OVER 1 HOUR.. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, AMBIEN, HYDROCODONE BITARTRATE, LORAZEPAM, LUNESTA, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4687956-7
Cetuximab side effect was reported by a Health Professional from on June 08, 2005. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE TARTRATE. Patient recovered.

Cetuximab Side Effects Report #5405161-3
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2007. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer, lung neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: atrial fibrillation

, dehydration, febrile neutropenia, haemoglobin decreased, metastases to lymph nodes, pneumonia primary atypical, respiratory failure, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 05/30/2007.

Cetuximab Side Effects Report #4746843-6
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2005. Male patient, 71 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, fatigue, haemoglobin decreased, hyperkalaemia, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4798836-0
Cetuximab side effect was reported by a Health Professional from GERMANY on Oct 11, 2005. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer, myalgia and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: granulocytes abnormal, haemoglobin decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE, TRAMADOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4811453-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: culture positive, haemoglobin decreased, pneumonia

, staphylococcal infection

. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4881851-6
Cetuximab side effect was reported by a Health Professional from GERMANY on Oct 11, 2005. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer, myalgia and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: granulocytes abnormal, haemoglobin decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE, TRAMADOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4577309-4
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 04, 2005. Male patient, 67 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lung infection pseudomonal, lung infiltration, neutropenia, pneumonitis. Cetuximab dosage: INITIATED 02-NOV-04. INDUCTION DOSE 400 MG/M2 WK.1. TOTAL DOSE FROM 02-NOV-04 TO 17-JAN-05 5574 MG.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ARANESP, NEULASTA. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4705280-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 27, 2005. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypoxia, neutrophil count decreased, pulmonary embolism

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, COUMADIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4708014-9
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2005. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypoxia, neutrophil count decreased, pulmonary embolism

. Cetuximab dosage: ADMINISTERED OVER 1 HOUR. INITIAL TX DATE: 06-JUN-05, 400 MG/M2.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, COUMADIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4743829-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2005. Male patient, 67 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pneumonitis, sepsis

. Cetuximab dosage: ADMIN OVER 1 HOUR/DOSE HELD (NO DATE)/470 MG TOTAL DOSE ADMINISTERED THIS COURSE.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 08/04/2005.

Cetuximab Side Effects Report #5215997-X
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, febrile neutropenia, haematocrit decreased, haemoglobin decreased, heart rate increased, heart rate irregular, hypokalaemia, hypomagnesaemia, hyponatraemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, DURAGESIC, OXYCODONE, MAXIPIME, VANCOMYCIN, PROTONIX. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4777139-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 16, 2005. Male patient, 63 years of age, weighting 304.2 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dizziness

, fall

, haemoglobin decreased, hypoaesthesia, hypotension, international normalised ratio increased, prothrombin time prolonged. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, SAW PALMETTO, METHOTREXATE, COUMADIN, ELAVIL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4582479-8
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 02, 2005. Female patient, 62 years of age, weighting 209.4 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: chills, constipation

, haemoglobin decreased, infected sebaceous cyst, infection

, neutrophil count decreased, platelet count decreased, sepsis

, urinary tract infection

, haemoglobin decreased, infection

, neutrophil count decreased, platelet count decreased, sepsis

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5499589-3
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2007. Female patient, 60 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, blood albumin decreased, dehydration, fatigue, febrile neutropenia, haemoglobin decreased, neuropathy, neutrophil count decreased, protein total increased. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5505185-1
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2007. Female patient, 60 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, blood albumin decreased, dehydration, fatigue, febrile neutropenia, haemoglobin decreased, neuropathy, neutrophil count decreased, protein total decreased. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4582719-5
Cetuximab side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 58 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, hypomagnesaemia, orthostatic hypotension, platelet count decreased, syncope, vertigo. Cetuximab dosage: INITIAL TX DATE:12-OCT-04/6488MG WAS TOTAL DOSE ADM THIS COURSE/LAST CYCLE HELD/NOT TO BE MADE UP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4601660-2
Cetuximab side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 58 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, hypomagnesaemia, platelet count decreased, syncope. Cetuximab dosage: INITIAL TX DATE:12-OCT-04/6488MG WAS TOTAL DOSE ADM THIS COURSE/LAST CYCLE HELD/NOT TO BE MADE UP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4757874-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Apr 18, 2005. Female patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cellulitis

, deep vein thrombosis

, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, neutrophil percentage decreased, phlebitis superficial, prothrombin time prolonged. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, COUMADIN, DYAZIDE, NORVASC, PROTONIX, TOPROL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4900077-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 25, 2006. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer, anaemia, blood magnesium decreased, pruritus, back pain

, glaucoma

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, pneumonia

, pulmonary haemorrhage. Cetuximab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, PROCRIT, MAGNESIUM OXIDE, BENADRYL, TYLENOL, IOPIDINE, COSOPT. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5269511-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastrointestinal ulcer, haemoglobin decreased, malignant neoplasm progression, stress ulcer. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 11/23/2006.

Cetuximab Side Effects Report #5173429-4
Cetuximab side effect was reported by a Physician from GERMANY on Dec 08, 2006. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastrointestinal ulcer, haemoglobin decreased. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient recovered.

Cetuximab Side Effects Report #4675815-5
Cetuximab side effect was reported by a Health Professional from on May 20, 2005. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: amnesia, confusional state, deep vein thrombosis

, disorientation, encephalopathy, enterococcal infection, haematocrit decreased, haemoglobin decreased, hyperkalaemia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, COUMADIN, INDOCIN, VICODIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4791210-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2005. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cough, fatigue, haemoglobin decreased, nausea

. Cetuximab dosage: 427 MG INITIATED ON 09-SEP-2005.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4819339-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2005. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cough, fatigue, haemoglobin decreased, nausea

. Cetuximab dosage: 427 MG INITIATED ON 09-SEP-2005.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5075521-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 52 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: breath sounds abnormal, chest pain

, chills, cough, crepitations, haematocrit decreased, haemoglobin decreased, haemoptysis, influenza like illness. Cetuximab dosage: 400MG/M2 IV. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4742989-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 29, 2005. Male patient, 51 years of age, weighting 178.6 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood chloride decreased, blood sodium decreased, disease progression, embolism, haemoglobin decreased, malignant neoplasm progression, palpitations, pulmonary embolism

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ATIVAN, COUMADIN, HYDROCHLOROTHIAZIDE, MORPHINE, PREDNISONE. Patient was hospitalized. Patient died on 07/18/2005.

Cetuximab Side Effects Report #5583135-X
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Female patient, 49 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, haemoglobin decreased, malignant neoplasm progression, sepsis

, stomatitis. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, BEVACIZUMAB. Patient was hospitalized. Patient died on 12/25/2007.

Cetuximab Side Effects Report #4758813-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 25, 2005. Female patient, 46 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dyspnoea, haemoglobin decreased, haemoptysis, pneumonia

. Cetuximab dosage: INI 712 MG 02-DEC-2005/445 MG 09-DEC-2005TO23-DEC-2005/448 MG 28-DEC-2005TO22-FEB-2006/INTERRUPTED.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4749769-7
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2005. Female patient, 69 years of age, weighting 130.1 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, chills, device failure, diarrhoea, haemoglobin decreased, hyperhidrosis, hyponatraemia, nausea

. Cetuximab dosage: INITIATED ON 10-JUN-2005/ADMIN WEEKS 2-6/TOTAL DOSE THIS COURSE = 410 MG.. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5256153-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Feb 26, 2007. Male patient, 66 years of age, weighting 134.5 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, blood albumin decreased, blood magnesium decreased, diarrhoea, haemoglobin decreased, nausea

, stomatitis, weight decreased, white blood cell disorder. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5709032-4
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2008. Male patient, 48 years of age, weighting 191.6 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: atelectasis, blood culture positive, collapse of lung, disease progression, dyspnoea, haematocrit decreased, haemoglobin decreased, lung abscess, lymphadenopathy. Cetuximab dosage: 500 MG/M2 EVERY 2 WEEKS IV. During the same period patient was treated with FENTANYL CITRATE, DOCUSATE, PROMETHAZINE W, SYMBICORT. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5481681-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2007. Female patient, 17 years of age, was diagnosed with neoplasm and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, diarrhoea, febrile neutropenia, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypomagnesaemia, nausea

, neutrophil count decreased. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4691713-5
Cetuximab side effect was reported by a Consumer or non-health professional from on June 11, 2005. Female patient, 55 years of age, weighting 202.8 lb, was diagnosed with metastatic renal cell carcinoma, deep vein thrombosis

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, haemoglobin decreased, varices oesophageal. Cetuximab dosage: 400 MG/M2 IV OVER 120 MIN D1/250 MG/M2 IV OVER 60 MIN D8, 15, 22.. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4784369-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 29, 2005. Male patient, 53 years of age, weighting 126.0 lb, was diagnosed with lung neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cough, fatigue, haemoglobin decreased, lung infiltration, nausea

. Cetuximab dosage: 427 MG IV / 171 MG IV IV DRIP. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4784369-4
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 29, 2005. Male patient, 53 years of age, weighting 126.0 lb, was diagnosed with lung neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cough, fatigue, haemoglobin decreased, lung infiltration, nausea

. Cetuximab dosage: 427 MG IV / 171 MG IV IV DRIP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5416830-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Female patient, weighting 204.0 lb, was diagnosed with lung neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, upper gastrointestinal haemorrhage. Cetuximab dosage: 500MG WEEKLY IV. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4675786-1
Cetuximab side effect was reported by a Health Professional from on May 11, 2005. Female patient, 59 years of age, was diagnosed with lung cancer metastatic, hypertension and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anxiety

, blood pressure increased, depression

, dyspnoea, escherichia urinary tract infection, haemoglobin decreased, infusion related reaction, mitral valve incompetence, muscle twitching. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, LISINOPRIL, NEURONTIN, VITAMIN, ULTRACET, AMBIEN, LEXAPRO. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5128773-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Male patient, 59 years of age, weighting 149.9 lb, was diagnosed with laryngeal cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, hypoalbuminaemia, hypomagnesaemia, hyponatraemia, neutrophil count decreased, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5147933-9
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Male patient, 47 years of age, weighting 132.3 lb, was diagnosed with laryngeal cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, blood calcium decreased, blood sodium decreased, chills, dehydration, erythema, haemoglobin, haemoglobin decreased, hypocalcaemia. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5803195-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on July 02, 2008. Male patient, 66 years of age, weighting 134.5 lb, was diagnosed with head and neck cancer

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, blood albumin decreased, blood magnesium decreased, diarrhoea, fatigue, haemoglobin decreased, nausea

, stomatitis, weight decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5943797-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with head and neck cancer

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dysphagia, haemoglobin decreased, oropharyngeal pain, pharyngeal haemorrhage, soft tissue necrosis, trismus. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5893578-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 18, 2008. Male patient, 53 years of age, weighting 114.6 lb, was diagnosed with head and neck cancer

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyponatraemia, infection

, lymphopenia, neutrophil count decreased, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5422565-3
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Aug 21, 2007. Female patient, 86 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain upper, epistaxis, erythema, haemoglobin decreased, platelet count decreased, skin infection, splenomegaly, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4834432-4
Cetuximab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 15, 2005. Male patient, 72 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood potassium decreased, diarrhoea, fall

, haemoglobin decreased, head injury, hypotension, neutropenia. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, WARFARIN, GRANISETRON. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5130461-4
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient died on 02/25/2005.

Cetuximab Side Effects Report #5138529-3
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient died on 02/25/2005.

Cetuximab Side Effects Report #4640403-3
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, colorectal cancer metastatic, confusional state, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, lethargy. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4841710-1
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5951881-1
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 2008. Male patient, 62 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: colorectal cancer metastatic, diarrhoea, haemoglobin decreased, malignant neoplasm progression, stomatitis. Cetuximab dosage: unknown. During the same period patient was treated with FOLINIC ACID, IRINOTECAN, FLUOROURACIL. Patient was hospitalized. Patient died.

Cetuximab Side Effects Report #4809008-5
Cetuximab side effect was reported by a Health Professional from GERMANY on Sept 13, 2005. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, cardiac failure, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, platelet count decreased, renal failure, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, ALLOPURINOL, AMIODARONE, DICLOFENAC, ENALAPRIL MALEATE, FUROSEMIDE, LEVOTHYROXINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 09/11/2005.

Cetuximab Side Effects Report #5752061-5
Cetuximab side effect was reported by a Health Professional from GERMANY on May 19, 2008. Male patient, 59 years of age, was diagnosed with colorectal cancer metastatic, hypertension, prophylaxis and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased. Cetuximab dosage: unknown. During the same period patient was treated with PRAVASTATIN, LISINOPRIL, IRINOTECAN, FOLINIC ACID, FLUOROURACIL, ASPIRIN, TENORMIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5444427-8
Cetuximab side effect was reported by a Health Professional from BRAZIL on Aug 08, 2007. Male patient, 57 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, haemoglobin decreased, leukopenia, metabolic acidosis, nausea

, pain

, platelet count decreased. Cetuximab dosage: 250 MILLIGRAM/SQ. METER 1/1 WEEK; IVD. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient died.

Cetuximab Side Effects Report #4746103-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2005. Male patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, hyperthermia, platelet count decreased, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4776147-7
Cetuximab side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 15, 2005. Female patient, 56 years of age, weighting 152.1 lb, was diagnosed with colorectal cancer metastatic, pain

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, headache

, hypersensitivity, nausea

, tachycardia. Cetuximab dosage: LOADING DOSE 682.28 MG ON 08-MAR-2005. FOLLOWED BY WEEKLY DOSE 426.43 MG FROM 22-MAR TO 26-APR-2005.. During the same period patient was treated with PARACETAMOL, PROMETHAZINE, IBUPROFEN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4675336-X
Cetuximab side effect was reported by a Health Professional from on Mar 22, 2005. Male patient, 80 years of age, was diagnosed with colorectal cancer

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cellulitis

, diarrhoea, haemoglobin decreased, hypomagnesaemia, neutropenia, skin candida, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5499168-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2007. Female patient, 47 years of age, weighting 154.3 lb, was diagnosed with colorectal cancer

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, constipation

, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypokalaemia, malignant neoplasm progression, oedema peripheral. Cetuximab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient died on 09/22/2007.

Cetuximab Side Effects Report #5651423-4
Cetuximab side effect was reported by a Consumer or non-health professional from FRANCE on Feb 26, 2008. Female patient, 70 years of age, was diagnosed with colon cancer stage iii and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, protein total increased, pyelonephritis, renal abscess, urinary tract infection

, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4664312-9
Cetuximab side effect was reported by a Health Professional from on May 13, 2005. Female patient, 64 years of age, weighting 83.78 lb, was diagnosed with cervix carcinoma recurrent, hypertension, anaemia and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, electrolyte imbalance, fatigue, haematocrit decreased, haemoglobin decreased, ileus, loss of consciousness, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, ATENOLOL, EPOGEN. Patient was hospitalized. Patient died on 05/10/2005.

Cetuximab Side Effects Report #5755951-2
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2008. Female patient, 42 years of age, weighting 160.9 lb, was diagnosed with cervix carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain

, haematocrit decreased, haemoglobin decreased, metastases to abdominal cavity, pyrexia. Cetuximab dosage: unknown. During the same period patient was treated with BENADRYL, MORPHINE, PHENERGAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5199723-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 29, 2006. Male patient, 79 years of age, weighting 145.5 lb, was diagnosed with biliary cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, disease progression, dyspnoea, fatigue, haemoglobin decreased, headache

, hypoalbuminaemia. Cetuximab dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, DRAMAMINE, NIFEDIPINE, POTASSIUM CHLORIDE, TOPROL, LIPITOR, FLOMAX, REQUIP. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5224063-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 26, 2007. Male patient, 79 years of age, weighting 145.5 lb, was diagnosed with biliary cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, fatigue, haemoglobin decreased, headache

, hypoalbuminaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, DRAMAMINE, NIFEDIPINE, POTASSIUM CHLORIDE, TOPROL, LIPITOR, FLOMAX, REQUIP. Patient was hospitalized. Patient died on 01/12/2007.

Cetuximab Side Effects Report #5485689-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Female patient, 62 years of age, weighting 209.4 lb, was diagnosed with anal cancer

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: deep vein thrombosis

, diarrhoea, fatigue, haemoglobin decreased, hypophosphataemia, platelet count decreased, proctalgia, radiation skin injury, white blood cell count decreased. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5723611-X
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Apr 22, 2008. Male patient, 62 years of age, weighting 116.8 lb, was treated with Cetuximab. After drug was administered, patient experienced the following side effects: bacteraemia, blood creatinine increased, blood potassium decreased, dehydration, dermatitis, dry skin, dysphagia, haemoglobin decreased, hypocalcaemia. Cetuximab dosage: START DATE OF FIRST COURSE:04FEB08. 98MG TOTAL DOSE ON 04MAR08. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Cetuximab and haemoglobin decreased

SideEffects101.com

Cetuximab and haemoglobin decreased Patient Reports February 11, 2012

side effects of Cetuximab